Vimarsana
Biggest News Aggregation in the World

Page 29 - Immunic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Today - Breaking & Trending Today

Immunic, Inc. Announces Completion of Enrollment of its Phase 2 CALDOSE-1 Trial of IMU-838 in Moderate-to-Severe Ulcerative Colitis - Vimarsana News

Immunic, Inc. Announces Completion of Enrollment of its Phase 2 CALDOSE-1 Trial of IMU-838 in Moderate-to-Severe Ulcerative Colitis

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment...

DGAP-News: Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935 - Vimarsana News

DGAP-News: Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935

DGAP-News: Immunic, Inc. / Key word(s): Study Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935 27.10.2021 / 12:30 The issuer is solely

DGAP-News: Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer - Vimarsana News

DGAP-News: Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer

DGAP-News: Immunic, Inc. / Key word(s): Personnel Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer 14.10.2021 / 12:30 The issuer is solely responsible for the content

Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer - Vimarsana News

Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

MUNIC: H1 2021 RESULTS - Vimarsana News

MUNIC: H1 2021 RESULTS

Net rebound in business after a year severely impacted by the pandemic Strong improvement in adjusted EBITDA, operating income and net income in H1 2021 Available cash of €6.7M at June 30th, 2021 2021